Journal of Clinical Endocrinology & Metabolism, Vol 80, 1783-1788, Copyright © 1995 by Endocrine Society

ARTICLES

A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women

AJ O'Sullivan and KK Ho
Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Previous studies have shown that oral, but not transdermal, administration of estrogen stimulates GH secretion in postmenopausal women. Because GH impairs insulin action, the impact of estrogen replacement therapy on carbohydrate metabolism may be influenced by the route of administration. The aim of this study was to prospectively compare the effects of oral and transdermal estrogen replacement on glucose tolerance and insulin sensitivity in postmenopausal women. In an open label, randomized, cross-over study, nine postmenopausal women were randomized to transdermal estrogen patches (Estraderm-TTS 100) or oral conjugated estrogen (Premarin, 1.25 mg) daily for 12 weeks and then crossed over to receive the alternative treatment for a further 12 weeks. An oral glucose tolerance test and hyperinsulinemic euglycemic clamp (HEC) were performed before treatment and at the end of 10 weeks of treatment. Oral and transdermal estrogen both significantly reduced LH to the same degree. Mean GH did not significantly change with transdermal estrogen, but rose significantly during oral estrogen therapy. Peak and mean glucose and insulin levels during the oral glucose tolerance test were not altered by estrogen therapy and were not significantly different between treatments. Mean glucose and insulin levels were maintained at an identical level during the HEC performed at pretreatment and during estrogen therapy. The mean glucose infusion rate required to maintain euglycemia during the HEC (mean +/- SEM, pretreatment, 40.4 +/- 4.8 mumol/kg.min) was unaltered by oral (39.8 +/- 4.6 mumol/kg.min) or transdermal estrogen treatment (42.1 +/- 4.2 mumol/kg.min). However, during the transdermal estrogen phase (60 +/- 10 mumol/L), the mean nonesterified free fatty acid concentration was suppressed to a significantly lower level during the HEC than during the oral estrogen phase (120 +/- 20 mumol/L; P < 0.05). We conclude that compared to the oral route, transdermal estrogen therapy is associated with a slight, but significant, improvement of insulin action on lipid metabolism. However, in the short term, the route of estrogen replacement therapy does not have a major impact on glucose metabolism in postmenopausal women.

This article has been cited by other articles:

				H. Gao, G. Bryzgalova, E. Hedman, A. Khan, S. Efendic, J.-A. Gustafsson, and K. Dahlman-Wright Long-Term Administration of Estradiol Decreases Expression of Hepatic Lipogenic Genes and Improves Insulin Sensitivity in ob/ob Mice: A Possible Mechanism Is through Direct Regulation of Signal Transducer and Activator of Transcription 3 Mol. Endocrinol., June 1, 2006; 20(6): 1287 - 1299. [Abstract] [Full Text] [PDF]

				D.-J. Kim and E. Barrett-Connor Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the rancho bernardo study. Diabetes Care, March 1, 2006; 29(3): 618 - 624. [Abstract] [Full Text] [PDF]

				C. K. Sites, G. D. L'Hommedieu, M. J. Toth, M. Brochu, B. C. Cooper, and P. A. Fairhurst The Effect of Hormone Replacement Therapy on Body Composition, Body Fat Distribution, and Insulin Sensitivity in Menopausal Women: A Randomized, Double-Blind, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2701 - 2707. [Abstract] [Full Text] [PDF]

				K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]

				Body Mass Index and Insulin Resistance Obstet. Gynecol., October 1, 2004; 104(4_suppl): 5S - 10S. [Full Text] [PDF]

				R. Rossi, G. Origliani, and M. G. Modena Transdermal 17-{beta}-Estradiol and Risk of Developing Type 2 Diabetes in a Population of Healthy, Nonobese Postmenopausal Women Diabetes Care, March 1, 2004; 27(3): 645 - 649. [Abstract] [Full Text] [PDF]

				C. A. Lissett and S. M. Shalet The Impact of Dose and Route of Estrogen Administration on the Somatotropic Axis in Normal Women J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4668 - 4672. [Abstract] [Full Text] [PDF]

				J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, and L. V. Campbell Moderate Alcohol Consumption, Estrogen Replacement Therapy, and Physical Activity Are Associated With Increased Insulin Sensitivity: Is abdominal adiposity the mediator? Diabetes Care, October 1, 2003; 26(10): 2734 - 2740. [Abstract] [Full Text] [PDF]

				R. E. Van Pelt, W. S. Gozansky, R. S. Schwartz, and W. M. Kohrt Intravenous estrogens increase insulin clearance and action in postmenopausal women Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E311 - E317. [Abstract] [Full Text] [PDF]

				M. Okada, S. Nomura, Y. Ikoma, E. Yamamoto, T. Ito, T. Mitsui, K. Tamakoshi, and S. Mizutani Effects of Postmenopausal Hormone Replacement Therapy on HbA1c Levels Diabetes Care, April 1, 2003; 26(4): 1088 - 1092. [Abstract] [Full Text] [PDF]

				A. M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, V. Bittner, J. A. Cauley, and E. Barrett-Connor Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, January 7, 2003; 138(1): 1 - 9. [Abstract] [Full Text] [PDF]

				K.-C. Leung, C. Howe, L. Y.-Y. Gui, G. Trout, J. D. Veldhuis, and K. K. Y. Ho Physiological and pharmacological regulation of 20-kDa growth hormone Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E836 - E843. [Abstract] [Full Text] [PDF]

				A. Cagnacci, A. M. Paoletti, A. Zanni, S. Arangino, G. Ibba, M. Orru, G. B. Melis, and A. Volpe Raloxifene Does Not Modify Insulin Sensitivity and Glucose Metabolism in Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4117 - 4121. [Abstract] [Full Text] [PDF]

				Y. Zhang, B. V. Howard, L. D. Cowan, J. Yeh, C. F. Schaefer, R. A. Wild, W. Wang, and E. T. Lee The Effect of Estrogen Use on Levels of Glucose and Insulin and the Risk of Type 2 Diabetes in American Indian Postmenopausal Women : The Strong Heart Study Diabetes Care, March 1, 2002; 25(3): 500 - 504. [Abstract] [Full Text] [PDF]

				A. S. Ryan, B. J. Nicklas, and D. M. Berman Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women Diabetes Care, January 1, 2002; 25(1): 127 - 133. [Abstract] [Full Text] [PDF]

				T. Wolthers, D. M. Hoffman, A. G. Nugent, M. W Duncan, M. Umpleby, and K. K. Y. Ho Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1191 - E1196. [Abstract] [Full Text] [PDF]

				E. M. McConnell, A. B. Atkinson, C. Ennis, D. R. Hadden, D. R. McCance, B. Sheridan, and P. M. Bell The Effects on Insulin Action in Adult Hypopituitarism of Recombinant Human GH Therapy Individually Titrated for Six Months J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5342 - 5347. [Abstract] [Full Text] [PDF]

				A. J. O'Sullivan, A. Martin, and M. A. Brown Efficient Fat Storage in Premenopausal Women and in Early Pregnancy: A Role for Estrogen J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4951 - 4956. [Abstract] [Full Text] [PDF]

				A. M. Oleksik, T. Duong, N. Pliester, G. Asma, C. Popp-Snijders, and P. Lips Effects of the Selective Estrogen Receptor Modulator, Raloxifene, on the Somatotropic Axis and Insulin-Glucose Homeostasis J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2763 - 2768. [Abstract] [Full Text] [PDF]

				S. Vehkavaara, J. Westerbacka, T. Hakala-Ala-Pietilä, A. Virkamäki, O. Hovatta, and H. Yki-Järvinen Effect of Estrogen Replacement Therapy on Insulin Sensitivity of Glucose Metabolism and Preresistance and Resistance Vessel Function in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4663 - 4670. [Abstract] [Full Text]

				R. J. TROISI, C. C. COWIE, and M. I. HARRIS Hormone Replacement Therapy and Glucose Metabolism Obstet. Gynecol., November 1, 2000; 96(5): 665 - 670. [Abstract] [Full Text] [PDF]

				G. Y. W. Kam, K.-C. Leung, R. C. Baxter, and Ken. K. Y. Ho Estrogens Exert Route- and Dose-Dependent Effects on Insulin-Like Growth Factor (IGF)-Binding Protein-3 and the Acid-Labile Subunit of the IGF Ternary Complex J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1918 - 1922. [Abstract] [Full Text]

				B. Guerci, H. Antebi, L. Meyer, V. Durlach, O. Ziegler, J.-P. Nicolas, L.-G. Alcindor, and P. Drouin Increased Ability of LDL from Normolipidemic Type 2 Diabetic Women to Generate Peroxides Clin. Chem., September 1, 1999; 45(9): 1439 - 1448. [Abstract] [Full Text] [PDF]

				P. Vestergaard, A. P. Hermann, H. Ørskov, and L. Mosekilde Effect of Sex Hormone Replacement on the Insulin-Like Growth Factor System and Bone Mineral: A Cross-Sectional and Longitudinal Study in 595 Perimenopausal Women Participating in the Danish Osteoporosis Prevention Study J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2286 - 2290. [Abstract] [Full Text]

				A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407. [Abstract] [Full Text]

				M. Christopher, F. L. Hew, M. Oakley, C. Rantzau, and F. Alford Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone Therapy J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1668 - 1681. [Abstract] [Full Text]